Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer
AUTOR(ES)
Ross, J R
FONTE
BMJ Publishing Group Ltd.
RESUMO
Objective To review the evidence for the use of bisphosphonates to reduce skeletal morbidity in cancer patients with bone metastases.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=188427Documentos Relacionados
- Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer
- Bisphosphonates and skeletal morbidity in patients with metastatic cancer
- Bisphosphonates reduce skeletal morbidity in cancer patients
- Bisphosphonates for metastatic breast cancer
- The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells
